English
简体
繁體中文
日本語
General Contact
About
Company
Mission & Vision
What We Do
Leadership Team
About JSR Life Sciences
Scientific Advisors
Strategic Partners
Careers
News
CVMD
Oncology
Menu Column 1
In Vivo
Services
Breast Cancer Preclinical Models
Cell Line Derived Xenograft Models
Cell Line and Model Authentication
Custom Tumor Model Development
Immuno-Oncology Models
MuScreen
Orthotopic and Bioluminescent Models
Patient-Derived Xenograft Models (HuPrime/HuKemia)
Prostate Cancer Preclinical Models
Radiation Therapy
Syngeneic Tumor Models
Menu Column 2
In Vitro
Services
Cell Based Screening
CrownSyn
Cell Line and Model Authentication
Cell Line Panels
Flow Cytometry Platform
Immuno-Oncology
OmniScreen Cell Based Screening Service
PDX-Derived Cell Lines
Organoids
Cell Line and Model Authentication
Organoid and Immune
Cell Co-Culture
Ex Vivo
Services
3D Assays
Tumor Microarrays
Menu Column 3
Immuno-Oncology
CAR-T Cell Therapy Models
Humanized Models
Hematopoietic Stem Cell (HSC)-PDX
MiXeno
Human Target Knock-In Models
HuGEMM
HuCELL
Murine Immunity Models and Services
Tumor Homograft Models
Syngeneic Tumor Models
MuScreen
Mouse I/O RNA-Seq Panel
Biomarker Discovery and CDx
Biomarkers of Response (HuMark)
Mouse Clinical Trials (HuTrial)
Signatures of Response (HuSignature)
Menu Column 4
Biomarker Assay Services
Cytokine and Chemokine Profiling
Flow Cytometry
Genomics Services
Mouse I/O RNA-Seq Panel
Histology and Digital Pathology
Rare Cell Analysis
Bioinformatics
CrownSyn
Pharmacology and Bioanalytical Services
DMPK Services
Rodent Immuno-Safety Models
Rodent Safety Pharmacology
Structural Biology
Target Validation
Oncology Databases
HuBase
OrganoidBase
MuBase
Onco
Express
XenoBase
Inflammation
Menu Column 1
In Vivo
Models
Inflammatory Bowel Disease (IBD)
MS-NASH (FATZO)
Rheumatoid Arthritis (RA)
Rodent Models of Diabetes
Menu Column 2
Biomarker Assay Services
Cytokine and Chemokine Profiling
Flow Cytometry
Genomics Services
Histology and Digital Pathology
Rare Cell Analysis
Models
Cell Line Derived Xenograft
HSC and PBMC Humanized
Human Target Knock-In ( HuGEMM
TM
)
Patient-Derived Xenograft ( HuPrime
TM
)
Syngeneic
Tumor Homograft ( MuPrime
TM
)
Resources
Posters
Publications
Presentations
White Papers
On-Demand Webinars
Events
Quick Facts
FactSheets
Application Notes
Blog
Databases
HuBase
OrganoidBase
MuBase
Onco
Express
XenoBase
Search
Site Search 360
Call
Email
About
Company
Mission & Vision
What We Do
Leadership Team
About JSR Life Sciences
Scientific Advisors
Strategic Partners
News
Oncology
In Vivo
Services
Breast Cancer Preclinical Models
Cell Line Derived Xenograft Models
Cell Line and Model Authentication
Custom Tumor Model Development
Immuno-Oncology Models
MuScreen
Orthotopic and Bioluminescent Models
Patient-Derived Xenograft Models
Prostate Cancer Preclinical Models
Radiation Therapy
Syngeneic Tumor Models
In Vitro
Services
Cell Based Screening
CrownSyn
Cell Line and Model Authentication
Cell Line Panels
Flow Cytometry Platform
Immuno-Oncology
OmniScreen Cell Based Screening Service
PDX Derived Cell Lines
Organoids
Cell Line and Model Authentication
Organoid and Immune Cell Co-Culture
Ex Vivo
Services
3D Assays
Tumor Microarrays
Immuno-Oncology
CAR-T Cell Therapy Models
Humanized Models
Hematopoietic stem cell (HSC)-PDX
HuGEMM
HuCELL
MiXeno
Murine Immunity Models and Services
Tumor Homograft Models
Syngeneic Tumor Models
MuScreen
Mouse I/O RNA-Seq Panel
Biomarker Discovery and CDx
Biomarkers of Response (HuMark)
Mouse Clinical Trials (HuTrial)
Signatures of Response (HuSignature)
Biomarker Assay Services
Cytokine and Chemokine Profiling
Flow Cytometry
Genomics Services
Mouse I/O RNA-Seq Panel
Histology and Digital Pathology
Rare Cell Analysis
Bioinformatics
CrownSyn
Pharmacology and Bioanalytical Services
DMPK Services
Rodent Immuno-Safety Models
Rodent Safety Pharmacology
Structural Biology
Target Validation
Oncology Databases
HuBase
OrganoidBase
MuBase
Onco
Express
XenoBase
Inflammation
In Vivo
Models
Inflammatory Bowel Disease
MS-NASH (FATZO)
Rheumatoid Arthritis (RA)
Rodent Models of Diabetes
Biomarker Servicers
Cytokine and Chemokine Profiling
Flow Cytometry Platform
Genomics Services
Histology and Digital Pathology Platform
Rare Cell Analysis
Models
Cell Line Derived Xenograft
HSC and PBMC Humanized
Human Target Knock-In ( HuGEMM
TM
)
Patient-Derived Xenograft ( HuPrime
TM
)
Syngeneic
Tumor Homograft ( MuPrime
TM
)
Resources
Posters
Publications
Presentations
White Papers
On-Demand Webinars
Events
Quick Facts
FactSheets
Application Notes
Blog
Databases
Onco
Express
HuBase
OrganoidBase
XenoBase
MuBase
Contact
x
Example Individual Model
Breast Cancer PDX Model: BR0438
BR0438 is a HER2+, PR-, ER- breast cancer PDX model
Model Information:
Patient Data
Growth Characteristics
Additional Characteristics